SODIUM CHANNELOPATHIES OF SKELETAL MUSCLE AND BRAIN

被引:60
|
作者
Mantegazza, Massimo [1 ,2 ,3 ]
Cestele, Sandrine [1 ,2 ]
Catterall, William A. [4 ]
机构
[1] Univ Cote dAzur, Valbonne, France
[2] CNRS, Inst Pharmacol Mol & Cellulaire, UMR7275, Valbonne, France
[3] INSERM, Valbonne, France
[4] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
autism; epilepsy; migraine; periodic paralysis; sodium channels; VOLTAGE-GATED SODIUM; SEVERE MYOCLONIC EPILEPSY; FAMILIAL HEMIPLEGIC MIGRAINE; HYPOKALEMIC PERIODIC PARALYSIS; CHANNEL ALPHA-SUBUNIT; ACTION-POTENTIAL INITIATION; DE-NOVO MUTATIONS; CORTICAL SPREADING DEPRESSION; NEONATAL-INFANTILE SEIZURES; AUTISM SPECTRUM DISORDER;
D O I
10.1152/physrev.00025.2020
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Voltage-gated sodium channels initiate action potentials in nerve, skeletal muscle, and other electrically excitable cells. Mutations in them cause a wide range of diseases. These channelopathy mutations affect every aspect of sodium channel function, including voltage sensing, voltage-dependent activation, ion conductance, fast and slow inactivation, and both biosynthesis and assembly. Mutations that cause different forms of periodic paralysis in skeletal muscle were discovered first and have provided a template for understanding structure, function, and pathophysiology at the molecular level. More recent work has revealed multiple sodium channelopathies in the brain. Here we review the well-characterized genetics and pathophysiology of the periodic paralyses of skeletal muscle and then use this information as a foundation for advancing our understanding of mutations in the structurally homologous alpha-subunits of brain sodium channels that cause epilepsy, migraine, autism, and related comorbidities. We include studies based on molecular and structural biology, cell biology and physiology, pharmacology, and mouse genetics. Our review reveals unexpected connections among these different types of sodium channelopathies.
引用
收藏
页码:1633 / 1689
页数:57
相关论文
共 50 条
  • [21] Novel Insights into the Pathomechanisms of Skeletal Muscle Channelopathies
    Burge, James A.
    Hanna, Michael G.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (01) : 62 - 69
  • [22] Skeletal muscle channelopathies: a guide to diagnosis and management
    Matthews, Emma
    Holmes, Sarah
    Fialho, Doreen
    PRACTICAL NEUROLOGY, 2021, 21 (03) : 196 - +
  • [23] Epilepsy and brain channelopathies from infancy to adulthood
    Bartolini, Emanuele
    Campostrini, Roberto
    Kiferle, Lorenzo
    Pradella, Silvia
    Rosati, Eleonora
    Chinthapalli, Krishna
    Palumbo, Pasquale
    NEUROLOGICAL SCIENCES, 2020, 41 (04) : 749 - 761
  • [24] Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children
    Al-Ghamdi, Fouad
    Darras, Basil T.
    Ghosh, Partha S.
    PEDIATRIC NEUROLOGY, 2017, 70 : 26 - 33
  • [25] Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis
    Rayan, Dipa L. Raja
    Hanna, Michael G.
    CURRENT OPINION IN NEUROLOGY, 2010, 23 (05) : 466 - 476
  • [26] Managing pregnancy and anaesthetics in patients with skeletal muscle channelopathies
    Rayan, Dipa L. Raja
    Hanna, Michael G.
    NEUROMUSCULAR DISORDERS, 2020, 30 (07) : 539 - 545
  • [27] Voltage-sensor mutations in channelopathies of skeletal muscle
    Cannon, Stephen C.
    JOURNAL OF PHYSIOLOGY-LONDON, 2010, 588 (11): : 1887 - 1895
  • [28] Measuring quality of life impairment in skeletal muscle channelopathies
    Sansone, V. A.
    Ricci, C.
    Montanari, M.
    Apolone, G.
    Rose, M.
    Meola, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (11) : 1470 - 1476
  • [29] Sodium channelopathies and pain
    Lampert, Angelika
    O'Reilly, Andrias O.
    Reeh, Peter
    Leffler, Andreas
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2010, 460 (02): : 249 - 263
  • [30] Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review
    Menezes, Luis Felipe Santos
    Sabia Junior, Elias Ferreira
    Tibery, Diogo Vieira
    Carneiro, Lilian dos Anjos
    Schwartz, Elisabeth Ferroni
    FRONTIERS IN PHARMACOLOGY, 2020, 11